Global Coronary Stent Market Hits $10.9 billion in 2025 with 5.1% CAGR

Published: Jan 2026

Global coronary stent market was valued at $10.9 billion in 2025 and is growing at a CAGR of 5.1% during the forecast period (2026-2035). Balloon-expandable stents play a central role in coronary stent interventions due to their controlled deployment, precise positioning, and strong radial support, which are critical in treating coronary artery disease. These stents are expanded using an inflatable balloon, allowing clinicians to achieve accurate placement within narrowed coronary arteries. The predictable expansion behavior supports optimal vessel scaffolding and uniform lesion coverage during percutaneous coronary interventions. Balloon-expandable stents are widely compatible with advanced drug-eluting technologies, contributing to reduced restenosis rates and improved long-term outcomes. The extensive clinical use, established procedural familiarity, and consistent performance across a wide range of coronary lesions reinforce their continued importance in coronary revascularization practices globally.

Browse the full report description of “Coronary Stent Market Size, Share & Trends Analysis by Mode of Delivery (Balloon-Expandable Stents, Self-Expanding Stents), By Type (Bare-Metal Stents, Drug-Eluting Stents, and Bioabsorbable Stents), Forecast Period (2026-2035)” at https://www.omrglobal.com/industry-reports/coronary-stent-market

Moreover, clinical evidence highlights the safety and effectiveness of drug-coated balloon therapies, increasing interest in implant-free or reduced-implant treatments and contributing to market growth in coronary interventions.For instance, in October 2025, new research from a Mount Sinai-led trial indicates that a new drug-eluting balloon, coated with sirolimus, demonstrates comparable safety and effectiveness to conventional metal stents for patients experiencing coronary in-stent restenosis during repeat percutaneous coronary interventions. This landmark US-regulated study is the largest randomized trial of its kind, potentially paving the way for a safer and more straightforward treatment option for these patients.

Key Innovators Driving Coronary Stent Transformation

The key players in the coronary stent market include Abbott Laboratories, Braun Melsungen AG, Boston Scientific Corp., Medtronic Plc, Terumo Corp., among others. These companies are driving innovation in digital health solutions such as telemedicine, electronic health records, remote patient monitoring, and AI-powered clinical tools, shaping the future of healthcare delivery globally.

  • In February 2025, UPMC Heart and Vascular Institute addressed the challenge of in-stent restenosis (ISR) in coronary artery disease (CAD) by utilizing the FDA-approved AGENT Drug-Coated Balloon (DCB). This innovative approach offers an alternative to the traditional method of placing additional stents, which can lead to complications such as increased metal burden and higher long-term restenosis risk. The interventional cardiology teams at UPMC are focusing on carefully selecting patients to optimize the use of DCB for ISR treatment.

Market Coverage

  • The market number available for – 2025-2035
  • Base year- 2025
  • Forecast period- 2026-2035
  • Segment Covered-
    • By Mode of Delivery
    • By Type
  • Regions Covered-
    • North America
    • Europe
    • Asia-Pacific
    • Rest of the World
  • Competitive Landscape - Abbott Laboratories, Braun Melsungen AG, Boston Scientific Corp., Medtronic Plc, Terumo Corp., among others.

Key questions addressed by the report.

  • What is the market growth rate?
  • Which segment and region dominate the market in the base year?
  • Which segment and region will project the fastest growth in the market?
  • Who is the leader in the market?
  • How are players addressing challenges to sustain growth?
  • Where is the investment opportunity?

Global Coronary Stent Market Report Segment

By Mode of Delivery

  • Balloon-Expandable Stents
  • Self-Expanding Stents

By Type

  • Bare-Metal Stents
  • Drug-Eluting Stents
  • Bioabsorbable Stents

Global Coronary Stent Market Report Segment by Region

North America

  • United States
  • Canada

Europe

  • UK
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe

Asia-Pacific

  • China
  • India
  • Japan
  • South Korea
  • Australia and New Zealand
  • ASEAN Economies
  • Rest of Asia-Pacific

Rest of the World

  • Latin America
  • Middle East & Africa

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/construction-chemicals-market-size